McCarthy Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

McCarthy Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50	Closed	-$1K	–	325
2022 Q1	$1K	Hold	50	–	–	﹤0.01%	328
2021 Q4	$1K	Hold	50	–	–	﹤0.01%	323
2021 Q3	$1K	Hold	50	–	–	﹤0.01%	335
2021 Q2	$1K	Hold	50	–	–	﹤0.01%	391
2021 Q1	$1K	Hold	50	–	–	﹤0.01%	350
2020 Q4	$1K	Buy	+50	New	+$1.66K	﹤0.01%	329

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

McCarthy Asset Management's ICPT Position: Q2 2022 in Review

McCarthy Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2022, closing a stake of 50 shares — an estimated $1K sold.

McCarthy Asset Management first reported a position in ICPT in Q4 2020 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 144 funds tracked by Wall St. Rank hold ICPT as of Q2 2022.

McCarthy Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 50 Intercept Pharmaceuticals, Inc. shares in Q2 2022, an estimated $1K.
McCarthy Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 6 quarters.
McCarthy Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $1K in Q1 2022.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.